Items where authors include "Whitaker, M.J."

Article

Whitaker, M.J., Debono, M. and Ross, R.J. orcid.org/0000-0001-9222-9678 (2023) Developing oral chronotherapy for cortisol replacement in congenital adrenal hyperplasia. Clinical Endocrinology. ISSN 0300-0664

Stachanow, V. orcid.org/0000-0003-0018-4623, Neumann, U., Blankenstein, O. orcid.org/0000-0003-1803-5589 et al. (9 more authors) (2023) Model-Informed target morning 17α-hydroxyprogesterone concentrations in dried blood spots for pediatric congenital adrenal hyperplasia patients. Pharmaceuticals, 16 (3). 464. ISSN 1424-8247

Debono, M. orcid.org/0000-0002-1059-9702, Elder, C.J. orcid.org/0000-0003-2390-5593, Lewis, J. et al. (8 more authors) (2023) Home waking salivary cortisone to screen for adrenal insufficiency. NEJM Evidence, 2 (2). ISSN 2766-5526

Michelet, R., Bindellini, D., Melin, J. et al. (7 more authors) (2023) Insights in the maturational processes influencing hydrocortisone pharmacokinetics in congenital adrenal hyperplasia patients using a middle-out approach. Frontiers in Pharmacology, 13. 1090554. ISSN 1663-9812

Whitaker, M.J., Huatan, H. and Ross, R.J. orcid.org/0000-0001-9222-9678 (2023) Chronotherapy based on modified-release hydrocortisone to restore the physiological cortisol diurnal rhythm. DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 13 (1). pp. 1-8. ISSN 2190-393X

Tonge, J.J., Keevil, B.G., Craig, J.N. et al. (3 more authors) (2022) Main salivary steroid collection in children under conditions replicating home sampling. Journal of Clinical Endocrinology and Metabolism, 107 (11). dgac419. pp. 3128-3136. ISSN 0021-972X

Newell-Price, J., Huatan, H., Quirke, J. et al. (7 more authors) (2021) An oral lipidic native testosterone formulation that is absorbed independent of food. European Journal of Endocrinology, 185 (5). pp. 607-615. ISSN 0804-4643

Bonner, J.J., Burt, H., Johnson, T.N. et al. (3 more authors) (2021) Development and verification of an endogenous PBPK model to inform hydrocortisone replacement dosing in children and adults with cortisol deficiency. European Journal of Pharmaceutical Sciences, 165. 105913. ISSN 0928-0987

Neumann, U., Braune, K., Whitaker, M.J. et al. (7 more authors) (2021) A prospective study of children aged 0–8 years with CAH and adrenal insufficiency treated with hydrocortisone granules. The Journal of Clinical Endocrinology & Metabolism, 106 (3). e1433-e1440. ISSN 0021-972X

Nikolaou, N., Arvaniti, A., Appanna, N. et al. (13 more authors) (2020) Glucocorticoids regulate AKR1D1 activity in human liver in vitro and in vivo. Journal of Endocrinology, 245 (2). pp. 207-218. ISSN 0022-0795

Melin, J., Hartung, N., Parra-Guillen, Z.P. et al. (3 more authors) (2019) The circadian rhythm of corticosteroid-binding globulin has little impact on cortisol exposure after hydrocortisone dosing. Clinical Endocrinology, 91 (1). pp. 33-40. ISSN 0300-0664

Daniel, E. orcid.org/0000-0003-4699-420X, Whitaker, M.J. orcid.org/0000-0003-2388-4753, Keevil, B. orcid.org/0000-0002-0684-9318 et al. (2 more authors) (2018) Accuracy of hydrocortisone dose administration via nasogastric tube. Clinical Endocrinology, 90 (1). pp. 66-73. ISSN 0300-0664

Harrison, R.F., Debono, M., Whitaker, M.J. et al. (3 more authors) (2018) Salivary cortisone to estimate cortisol exposure and sampling frequency required based on serum cortisol measurements. Journal of Clinical Endocrinology and Metabolism. ISSN 0021-972X

Simpson, A. orcid.org/0000-0001-7880-4218, Ross, R., Porter, J. et al. (3 more authors) (2018) Adrenal insufficiency in young children : a mixed methods study of parents' experiences. Journal of Genetic Counseling, 27 (6). pp. 1447-1458.

Melin, J., Parra-Guillen, Z.P., Hartung, N. et al. (4 more authors) (2018) Predicting cortisol exposure from paediatric hydrocortisone formulation using a semi-mechanistic pharmacokinetic model established in healthy adults. Clinical Pharmacokinetics, 57. pp. 515-527. ISSN 0312-5963

Neumann, U., Whitaker, M.J., Wiegand, S. et al. (7 more authors) (2018) Absorption and tolerability of taste-masked hydrocortisone granules in neonates, infants and children under 6 years of age with adrenal insufficiency. Clinical Endocrinology, 88 (1). pp. 21-29. ISSN 0300-0664

Johnson, T.N., Whitaker, M.J., Keevil, B. et al. (1 more author) (2017) Bioavailability of oral hydrocortisone corrected for binding proteins and measured by LC-MS/MS using serum cortisol and salivary cortisone. Journal of Bioequivalence and Bioavailability, 10 (1). pp. 1-3. ISSN 0975-0851

Jones, C.M., Mallappa, A., Reisch, N. et al. (10 more authors) (2016) Modified release and conventional glucocorticoids and diurnal androgen excretion in congenital adrenal hyperplasia. Journal of Clinical Endocrinology and Metabolism. jc20162855. ISSN 0021-972X

Hummel, S.R., Sadler, S. orcid.org/0000-0001-5935-8507, Whitaker, M.J. et al. (3 more authors) (2016) A Model for Measuring the Health Burden of Classic Congenital Adrenal Hyperplasia in Adults. Clinical Endocrinology. ISSN 0300-0664

Debono, M., Harrison, R.F., Whitaker, M.J. et al. (4 more authors) (2016) Salivary Cortisone Reflects Cortisol Exposure Under Physiological Conditions and After Hydrocortisone. The Journal of Clinical Endocrinology & Metabolism, 101 (4). pp. 1469-1477. ISSN 0021-972X

Whitaker, M.J., Debono, M., Huatan, H. et al. (3 more authors) (2014) An oral multiparticulate, modified-release, hydrocortisone replacement therapy that provides physiological cortisol exposure. Clinical Endocrinology, 80 (4). pp. 554-561. ISSN 0300-0664